Positron emission tomography with the glucose analog [18F]- fluoro-2-deoxy-D-glucose for evaluating pelvic lymph node metastasis in uterine corpus cancer: Comparison with CT and MRI findings

Journal of Obstetrics and Gynaecology Research

Volumn 35, Issue 1, 2009, Pages 26-34

  Inubashiri, Eisuke ^a   Hata, Kohkichi ^b   Kanenishi, Kenji ^a   Shiota, Atsuko ^a   Ohno, Masayuki ^a   Yamamoto, Yuka ^a   Nishiyama, Yoshihiro ^a   Ohkawa, Motoomi ^a   Hata, Toshiyuki ^a  

^a KAGAWA UNIVERSITY   (Japan)

^b KAGAWA PREFECTURAL UNIVERSITY OF HEALTH SCIENCES   (Japan)

Author keywords

FDG PET; Pelvic lymph node metastasis; Uterine corpus cancer

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GLUCOSE DERIVATIVE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORRELATIONAL STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGING SYSTEM; LYMPH NODE METASTASIS; LYMPHADENECTOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; PELVIS LYMPH NODE; POSITRON EMISSION TOMOGRAPHY; SENSITIVITY AND SPECIFICITY; UTERUS CANCER;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; UTERINE NEOPLASMS;

EID: 58849107833     PISSN: 13418076     EISSN: 14470756     Source Type: Journal    
DOI: 10.1111/j.1447-0756.2008.00832.x     Document Type: Article

References (29)

1. Disaia PJ, Creasman WT, Boronow RC, Blessing JA. Risk factors and recurrent patterns in stage endometrial carcinoma. Am J Obstet Gynecol 1985 151 : 1009 1015.
2. International Federation of Gynecology and Obstetrics (FIGO). Annual report on the results of treatment in gynecologic cancer. Int J Gynecol Obstet 1989 28 : 189 190.
3. Greven KM, Curran WJ Jr., Whittington R et al. Analysis of failure patterns in stage III endometrial carcinoma and therapeutic implications. Int J Radiat Oncol Biol Phys 1989 17 : 35 39.
4. McMeekin DS, Lashbrook D, Gold M, Johnson G, Walker JL, Mannel R. Analysis of FIGO stage IIIc endometrial cancer patients. Gynecol Oncol 81 : 273 278.
5. Bristow RE, Zahurak ML, Alexander CJ, Zellars RC, Montz FJ. FIGO stage IIIC endometrial carcinoma: resection of macroscopic nodal disease and other determinants of survival. Int J Gynecol Cancer 2003 13 : 664 672.
6. Shepherd JH. Revised FIGO staging for gynaecological cancer. Br J Obstet Gynaecol 1989 96 : 889 892.
7. Schlaerth JB, Spirtos NM, Carson LF, Boike G, Adamec T, Stonebraker B. Laparoscopic retroperitoneal lymphadenectomy followed by immediate laparotomy in women with cervical cancer: a gynecologic oncology group study. Gynecol Oncol 2002 85 : 81 88.
8. Hertel H, Kohler C, Elhawary T, Michels W, Possover M, Schneider A. Laparoscopic staging compared with imaging techniques in the staging of advanced cervical cancer. Gynecol Oncol 2002 87 : 46 51.
9. Carrington B. Lymph nodes. In : Husband JES, Reznek RH (eds). Imaging in Oncology. Oxford : ISIS Medical Media, 1997 729 748.
10. Steinkamp HJ, Cornehl M, Hosten N, Pegios W, Vogl T, Felix R. Cervical lymphadenopathy: ratio of long- to short-axis diameter as a predictor of malignancy. Br J Radiol 1995 68 : 266 270.
11. Rockall AG, Sohaib SA, Harisinghani MG et al. Diagnostic performance of nanoparticle-enhanced magnetic resonance imaging in the diagnosis of lymph node metastases in patients with endometrial and cervical cancer. J Clin Oncol 2005 23 : 2813 2821.
12. Grigsby PW, Siegel BA, Dehdashti F, Mutch DG. Posttherapy surveillance monitoring of cervical cancer by FDG-PET. Int J Radiat Oncol Biol Phys 2003 55 : 907 913.
13. Hope AJ, Saha P, Grigsby PW. FDG-PET in carcinoma of the uterine cervix with endometrial extension. Cancer 2006 106 : 196 200.
14. 18F-FDG PET in the post-therapy surveillance of endometrial carcinoma. Eur J Nucl Med 2002 29 : 1132 1139.
15. Saga T, Higashi T, Ishimori T et al. Clinical value of FDG-PET in the follow up of post-operative patients with endometrial cancer. Ann Nucl Med 2003 17 : 193 203.
16. Zimny M, Siggelkow W, Schroder W et al. 2-[fluorine-18]-fluoro-2-deoxy-D- glucose positron emission tomography in the diagnosis of recurrent ovarian cancer. Gynecol Oncol 2001 83 : 310 315.
17. Sironi S, Messa C, Mangili G et al. Integrated FDG PET/CT in patients with persistent ovarian cancer: correlation with histologic findings. Radiology 2004 233 : 433 440.
18. Cohn DE, Dehdashti F, Gibb RK et al. Prospective evaluation of positron emission tomography for the detection of groin node metastases from vulvar cancer. Gynecol Oncol 2002 85 : 179 184.
19. Horowitz NS, Dehdashti F, Herzog TJ et al. Prospective evaluation of FDG-PET for detecting pelvic and para-aortic lymph node metastasis in uterine corpus cancer. Gynecol Oncol 2004 95 : 546 551.
20. Pandit-Taskar N. Oncologic imaging in gynecologic malignancies. J Nucl Med 2005 46 : 1842 1850.
21. Ascher SM, Reinhold C. Imaging of cancer of the endometrium. Radiol Clin N Am 2002 40 : 563 576.
22. Vorgias G, Katsoulis M, Argyrou K et al. Preoperative imaging of primary intra-abdominal gynaecological malignancies. Diagnostic accuracy of CT-scan and MRI. A Greek cohort study. Eur J Gynaecol Oncol 2002 23 : 139 144.
23. Rockall AG, Sohaib SA, Harisinghani MG et al. Diagnostic performance of nanoparticle-enhanced magnetic resonance imaging in the diagnosis of lymph node metastases in patients with endometrial and cervical cancer. J Clin Oncol 2005 23 : 2813 2821.
24. Marshall MJ, Goldberg DM, Neal FE, Millar DR. Enzymes of glucose metabolism in carcinoma of the cervix and endometrium of the human uterus. Br J Cancer 1978 37 : 990 1001.
25. Larson DM, Connor GP, Broste SK, Krawisz BR, Johnson KK. Prognostic significance of gross myometrial invasion with endometrial cancer. Obstet Gynecol 1996 88 : 394 398.
26. Frei KA, Kinkel K. Staging endometrial cancer: role of magnetic resonance imaging. J Magn Reson Imaging 2001 13 : 850 855.
27. Rieck GC, Bulman J, Whitaker R, Leeson SC. A retrospective review of magnetic resonance imaging in assessing the extent of myometrial infiltration for patients with endometrial carcinoma. J Obstet Gynaecol 2005 25 : 765 768.
28. Scheidler J, Hircak H, Yu KK, Subak L, Segal MR. Radiological evaluation of lymph node metastases in patients with cervical cancer: a meta-analysis. JAMA 1997 278 : 1096 1101.
29. Sironi S, Messa C, Mangili G et al. Integrated FDG PET/CT in patients with persistent ovarian cancer: correlation with histologic findings. Radiology 2004 233 : 433 444.